Trial NCT01174199

View at ClinicalTrials.gov 
Org. Study IDs: RPCI I 150709
Secondary IDs: NCI-2009-01537

Last trial update was posted on 2022-10-03

MeSH Interventions

MTOR Inhibitors Sirolimus Temsirolimus Vorinostat

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Stopping Reasons

no value in finding efficacy

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID